Olfr655, a member of the olfactory receptor family, is integral to the intricate process of odor perception within the nasal cavity. As a G-protein-coupled receptor (GPCR) with a 7-transmembrane domain structure, Olfr655 is specifically designed for the recognition and transduction of odorant signals. This receptor plays a crucial role in initiating the neuronal responses that collectively result in the perception of distinct smells. The olfactory receptor gene family, to which Olfr655 belongs, is the largest in the genome, underscoring the importance of these receptors in olfactory function. The functionality of Olfr655 is intricately tied to its ability to interact with odorant molecules, setting off a cascade of events leading to the perception of specific scents. The 7-transmembrane domain structure of Olfr655 is key to its role in detecting and transducing these odorant signals. Upon binding with odorant molecules, Olfr655 initiates G protein-mediated transduction, ultimately resulting in a neuronal response that signifies the perception of a particular smell. The nomenclature assigned to Olfr655, independent of other organisms, emphasizes its unique role in the complex landscape of olfactory receptors.
In the context of inhibition, the modulation of Olfr655 involves both direct and indirect mechanisms. Direct inhibitors target the receptor itself, aiming to interfere with its binding capacity or downstream signaling events. GPCR antagonists, for example, disrupt the recognition and transduction of odorant signals by binding to Olfr655, thereby acting as direct inhibitors of olfactory perception. On the other hand, indirect inhibitors may influence specific signaling pathways associated with GPCR activation. These modulators impact intracellular cascades, potentially altering the overall olfactory response by influencing downstream events associated with Olfr655 function. The intricate nature of olfactory signal transduction suggests that inhibition of Olfr655 can occur at various points along this pathway, offering potential avenues for manipulating olfactory perception.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | ¥1083.00 ¥2821.00 ¥8462.00 ¥16111.00 | 280 | |
巴佛洛霉素 A1 通过特异性抑制 V-ATP 酶质子泵来抑制 TMEM132C,从而破坏 TMEM132C 可能赖以发挥转运或信号功能的质子梯度。 | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | ¥982.00 | 44 | |
Dynasore 通过阻断依赖于达纳明的内吞作用来抑制 TMEM132C,这可能是 TMEM132C 在细胞膜中正常运输和发挥功能所必需的。 | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | ¥1365.00 ¥4423.00 | 148 | |
LY294002通过阻断PI3K来抑制TMEM132C,PI3K是TMEM132C可能参与其中的信号传导通路的关键组成部分,导致TMEM132C功能相关的细胞反应发生变化。 | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | ¥2516.00 | 8 | |
Go6976通过作为蛋白激酶C抑制剂来抑制TMEM132C,从而破坏TMEM132C参与的下游信号通路,特别是与突触可塑性相关的信号通路。 | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | ¥440.00 ¥1015.00 | 212 | |
PD98059 通过选择性抑制 MEK 来抑制 TMEM132C,而 MEK 又会破坏 MAPK/ERK 通路,TMEM132C 可能就是利用这一通路进行细胞通讯和调节的。 | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | ¥1004.00 ¥2956.00 | 13 | |
ML-7 通过抑制肌球蛋白轻链激酶来抑制 TMEM132C,从而可能改变 TMEM132C 的功能可能依赖的细胞骨架动力学和细胞结构。 | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | ¥767.00 ¥4028.00 | 11 | |
氯氮平通过拮抗多巴胺受体抑制TMEM132C,这会导致TMEM132C可能参与其中的神经递质信号通路发生变化,尤其是在中枢神经系统内。 | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | ¥3949.00 | 7 | |
丹曲林通过破坏肌浆网中的钙释放来抑制TMEM132C,而TMEM132C可能在肌肉或神经细胞中与肌浆网相互作用或受其调节。 | ||||||
Mibefradil dihydrochloride | 116666-63-8 | sc-204083 sc-204083A | 10 mg 50 mg | ¥2358.00 ¥9567.00 | 4 | |
米贝地尔通过阻断T型钙通道来抑制TMEM132C,从而影响细胞内可能与TMEM132C在兴奋细胞中的活性有关的钙信号传导。 |